| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Steven C George | |
| James L Puckett | |||
| P2860 | cites work | Exhaled nitric oxide measurements: clinical application and interpretation | Q24678480 |
| Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma | Q24678771 | ||
| Exhaled nitric oxide levels in non-allergic and allergic mono- or polysensitised children with asthma | Q28362224 | ||
| Airway nitric oxide diffusion in asthma: Role in pulmonary function and bronchial responsiveness | Q28376746 | ||
| Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly | Q29547442 | ||
| Respiratory nitric oxide levels in experimental human influenza | Q30472511 | ||
| Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. | Q31941303 | ||
| Increased nitric oxide in exhaled air after intake of a nitrate-rich meal | Q32058611 | ||
| Sputum eosinophils and exhaled nitric oxide during late asthmatic reaction in patients with western red cedar asthma | Q33860987 | ||
| Exhaled markers of pulmonary disease | Q34279117 | ||
| Increased amount of nitric oxide in exhaled air of asthmatics. | Q34290955 | ||
| Increased nitric oxide in exhaled air of asthmatic patients | Q34321842 | ||
| Mechanism of membrane damage mediated by human eosinophil cationic protein | Q34385508 | ||
| ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. | Q34409752 | ||
| Use of exhaled nitric oxide measurements to guide treatment in chronic asthma | Q34421179 | ||
| Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years | Q34424366 | ||
| Airway nitric oxide release is reduced after PBS inhalation in asthma | Q34582403 | ||
| Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans | Q34600899 | ||
| The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial | Q34627601 | ||
| Exhaled nitric oxide in childhood asthma | Q71611478 | ||
| High nitric oxide production in human paranasal sinuses | Q71803177 | ||
| Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide | Q72279828 | ||
| Exhaled nitric oxide partitioned into alveolar, lower airways and nasal contributions | Q73144626 | ||
| The relationship between airways inflammation and asthma severity | Q73321264 | ||
| Exhaled nitric oxide is reduced after sputum induction in asthmatic children | Q73815306 | ||
| The current single exhalation method of measuring exhales nitric oxide is affected by airway calibre | Q73966630 | ||
| Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation | Q74009204 | ||
| A single-breath technique with variable flow rate to characterize nitric oxide exchange dynamics in the lungs | Q74026481 | ||
| Expired nitric oxide after bronchoprovocation and repeated spirometry in patients with asthma | Q74363392 | ||
| Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma | Q74363456 | ||
| Exhaled nitric oxide measurements in a population sample of young adults | Q74529434 | ||
| Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness | Q74582008 | ||
| Orally exhaled nitric oxide levels are related to the degree of blood eosinophilia in atopic children with mild-intermittent asthma | Q74582014 | ||
| Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma | Q77747395 | ||
| The effect of cigarette smoking on exhaled nitric oxide in mild steroid-naive asthmatics | Q78053941 | ||
| NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma | Q78120709 | ||
| Level of exhaled nitric oxide during human anaphylaxis | Q80178582 | ||
| Differential flow analysis of exhaled nitric oxide in patients with asthma of differing severity | Q80312949 | ||
| Exhaled nitric oxide: interactions between asthma, hayfever, and atopic dermatitis in school children | Q80518860 | ||
| Exhaled NO: forward, backward, or sideways? | Q80642090 | ||
| Alveolar, but not bronchial nitric oxide production is elevated in cystic fibrosis | Q81517526 | ||
| Reduced exhaled nitric oxide in children after testing of maximal expiratory pressures | Q81633604 | ||
| Measurement of bronchial and alveolar nitric oxide production in normal children and children with asthma | Q83181703 | ||
| Smokers have reduced nitric oxide production by conducting airways but normal levels in the alveoli | Q94527623 | ||
| Airway remodeling in asthma | Q95825754 | ||
| Total and allergen-specific IgE levels in serum reflect blood eosinophilia and fractional exhaled nitric oxide concentrations but not pulmonary functions in allergic asthmatic children sensitized to house dust mites | Q45183014 | ||
| Effect of budesonide and montelukast in asthmatic children exposed to relevant allergens | Q45221558 | ||
| Sputum induction in children with difficult asthma: safety, feasibility, and inflammatory cell pattern | Q45242869 | ||
| A simple technique to characterize proximal and peripheral nitric oxide exchange using constant flow exhalations and an axial diffusion model. | Q45994046 | ||
| Flow-independent nitric oxide exchange parameters in cystic fibrosis. | Q46000401 | ||
| Probing the impact of axial diffusion on nitric oxide exchange dynamics with heliox. | Q46033155 | ||
| Exercise-induced bronchoconstriction alters airway nitric oxide exchange in a pattern distinct from spirometry | Q46065326 | ||
| Single-exhalation profiles of NO and CO2 in humans: effect of dynamically changing flow rate | Q46082857 | ||
| Effect of heterogeneous ventilation and nitric oxide production on exhaled nitric oxide profiles. | Q46098069 | ||
| A two-compartment model of pulmonary nitric oxide exchange dynamics | Q46127369 | ||
| Impact of high-intensity exercise on nitric oxide exchange in healthy adults | Q46159897 | ||
| Examining axial diffusion of nitric oxide in the lungs using heliox and breath hold | Q46232814 | ||
| A new and more accurate technique to characterize airway nitric oxide using different breath-hold times | Q46395932 | ||
| Alveolar nitric oxide and effect of deep inspiration during methacholine challenge | Q46486228 | ||
| Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma. | Q46522261 | ||
| Inflammatory response to sputum induction measured by exhaled markers | Q46575529 | ||
| Impact of axial diffusion on nitric oxide exchange in the lungs | Q46580269 | ||
| Effect of aspirin on airway inflammation and pulmonary function in patients with persistent asthma | Q46723598 | ||
| Increased bronchial NO output in severe atopic eczema in children and adolescents. | Q46826854 | ||
| Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma | Q46919055 | ||
| Correlation of exhaled nitric oxide, spirometry and asthma symptoms | Q47660032 | ||
| Peripheral inflammation in patients with asthmatic symptoms but normal lung function | Q47725895 | ||
| The relationship of exhaled nitric oxide to airway inflammation and responsiveness in children. | Q47760348 | ||
| Exhaled nitric oxide from lung periphery is increased in COPD. | Q47770379 | ||
| Exhaled nitric oxide as a screening tool for asthma in school children | Q47799251 | ||
| The effect of spirometry and exercise on exhaled nitric oxide in asthmatic children | Q47807964 | ||
| Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children | Q47849250 | ||
| Additive effect of eosinophilia and atopy on exhaled nitric oxide levels in children with or without a history of respiratory symptoms | Q47853669 | ||
| Effect of spirometric maneuver, nasal clip, and submaximal inspiratory effort on measurement of exhaled nitric oxide levels in asthmatic patients | Q47864296 | ||
| A prospective randomized study to evaluate the effect of leukodepletion on the rate of alveolar production of exhaled nitric oxide during cardiopulmonary bypass | Q47891257 | ||
| Source of exhaled nitric oxide in primary biliary cirrhosis | Q47896905 | ||
| Increase in alveolar nitric oxide in the presence of symptoms in childhood asthma | Q48009410 | ||
| Nitric oxide diffusing capacity and alveolar microvascular recruitment in sarcoidosis | Q48017139 | ||
| Effect of an inducible nitric oxide synthase inhibitor on differential flow-exhaled nitric oxide in asthmatic patients and healthy volunteers | Q34634687 | ||
| Exhaled nitric oxide in childhood asthma: a review | Q34724840 | ||
| Epithelial autotoxicity of nitric oxide: role in the respiratory cytopathology of pertussis | Q34937361 | ||
| IgE sensitisation in relation to flow-independent nitric oxide exchange parameters | Q35005572 | ||
| Multiple roles of nitric oxide in the airways. | Q35055532 | ||
| Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids. Asthma and Allergy Group | Q35532164 | ||
| Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma | Q35532923 | ||
| Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma | Q35533681 | ||
| Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma | Q35533687 | ||
| Dissociation between exhaled nitric oxide and hyperresponsiveness in children with mild intermittent asthma | Q35533844 | ||
| Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity | Q35534058 | ||
| Relationship between exhaled NO, respiratory symptoms, lung function, bronchial hyperresponsiveness, and blood eosinophilia in school children | Q35535737 | ||
| Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission | Q35537520 | ||
| Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma | Q35563919 | ||
| Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests | Q35564195 | ||
| Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma | Q35573129 | ||
| Modeling pulmonary nitric oxide exchange | Q35651184 | ||
| Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells | Q35832717 | ||
| Nitric oxide in health and disease of the respiratory system | Q35842979 | ||
| Modulation of nitric oxide pathways: therapeutic potential in asthma and chronic obstructive pulmonary disease | Q36391226 | ||
| Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics | Q40315613 | ||
| The biology of nitrogen oxides in the airways | Q40386353 | ||
| New insights into the regulation of inducible nitric oxide synthesis | Q40667715 | ||
| Expression of inducible nitric oxide in human lung epithelial cells. | Q41447712 | ||
| Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. | Q41537656 | ||
| Reduction in exhaled nitric oxide immediately after methacholine challenge in asthmatic children | Q41969750 | ||
| Increased alveolar nitric oxide concentration and high levels of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosis | Q41984856 | ||
| Expired nitric oxide levels during treatment of acute asthma | Q42061224 | ||
| Measurement of IL-13-induced iNOS-derived gas phase nitric oxide in human bronchial epithelial cells. | Q42509394 | ||
| Exhaled nitric oxide: a new lung function test | Q42611969 | ||
| Airway diffusing capacity of nitric oxide and steroid therapy in asthma | Q43498450 | ||
| Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients | Q43604746 | ||
| Low-dose theophylline reduces eosinophilic inflammation but not exhaled nitric oxide in mild asthma. | Q43681848 | ||
| Factors associated with persistent airflow limitation in severe asthma | Q43732321 | ||
| Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma | Q43804330 | ||
| Exhaled nitric oxide decreases during exercise-induced bronchoconstriction in children with asthma | Q43816362 | ||
| Airway inflammation is present during clinical remission of atopic asthma. | Q43819606 | ||
| Significant variability in response to inhaled corticosteroids for persistent asthma | Q43920193 | ||
| Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship | Q44162549 | ||
| Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma | Q44357077 | ||
| Correlations between exhaled nitric oxide levels, blood eosinophilia, and airway obstruction reversibility in childhood asthma are detectable only in atopic individuals. | Q44398397 | ||
| Assessment of inhaled BDP-dose dependency of exhaled nitric oxide and local and serum eosinophilic markers in steroids-naive nonatopic asthmatics. | Q44596926 | ||
| Relationship among pulmonary function, bronchial reactivity, and exhaled nitric oxide in a large group of asthmatic patients | Q44634868 | ||
| Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children | Q44650811 | ||
| Alveolar and airway sites of nitric oxide inflammation in treated asthma | Q44960159 | ||
| Both inflammation and remodeling influence nitric oxide output in children with refractory asthma | Q48021861 | ||
| Alveolar-derived exhaled nitric oxide is reduced in obstructive sleep apnea syndrome | Q48461837 | ||
| Validation of a standardized version of the Asthma Quality of Life Questionnaire | Q48763361 | ||
| Effect of atmospheric nitric oxide (NO) on measurements of exhaled NO in asthmatic children. | Q50869959 | ||
| Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. | Q51641626 | ||
| Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms. | Q51698789 | ||
| Increased nitric oxide elimination from the airways after smoking cessation. | Q51711957 | ||
| Partitioning of alveolar and conducting airway nitric oxide in scleroderma lung disease. | Q51713527 | ||
| Extended NO analysis applied to patients with COPD, allergic asthma and allergic rhinitis. | Q51726331 | ||
| Increased nitric oxide output from alveolar origin during liver cirrhosis versus bronchial source during asthma. | Q51729169 | ||
| Airway contribution to alveolar nitric oxide in healthy subjects and stable asthma patients. | Q51896167 | ||
| Reference values of pulmonary diffusing capacity for nitric oxide in an adult population. | Q51901664 | ||
| Simultaneous measurement of nitric oxide production by conducting and alveolar airways of humans. | Q52142296 | ||
| High-resolution computed tomography scan and airway remodeling in children with severe asthma. | Q53567413 | ||
| Airway nitric oxide output is reduced in bronchiectasis. | Q53580650 | ||
| Use of different exhaled nitric oxide multiple flow rate models in COPD. | Q54029120 | ||
| NO in Exhaled Air of Asthmatic Children Is Reduced by the Leukotriene Receptor Antagonist Montelukast | Q57638323 | ||
| Exhaled nitric oxide in 4-year-old children: relationship with asthma and atopy | Q58052665 | ||
| Increased bronchial nitric oxide production in patients with asthma measured with a novel method of different exhalation flow rates | Q58171248 | ||
| Effect of smoking on exhaled nitric oxide and flow-independent nitric oxide exchange parameters | Q58308468 | ||
| Exhaled nitric oxide before and after montelukast sodium therapy in school-age children with chronic asthma: A preliminary study | Q58387531 | ||
| Exhaled Nitric Oxide after β2-agonist Inhalation and Spirometry in Asthma | Q58387541 | ||
| Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide | Q58387555 | ||
| Differences in Airway Inflammation in Patients with Fixed Airflow Obstruction Due to Asthma or Chronic Obstructive Pulmonary Disease | Q58877288 | ||
| Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide in Adults and Children—1999 | Q59615965 | ||
| Exhaled nitric oxide during acute changes of airways calibre in asthma | Q63504926 | ||
| Epithelial injury by human eosinophils | Q67987800 | ||
| Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients | Q70839028 | ||
| Nasal contribution to exhaled nitric oxide at rest and during breathholding in humans | Q70906282 | ||
| Peroxynitrite induces airway hyperresponsiveness in guinea pigs in vitro and in vivo | Q71078926 | ||
| Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract | Q71147238 | ||
| Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients | Q71458085 | ||
| Induction of nitric oxide synthase in asthma | Q71601675 | ||
| P433 | issue | 1-3 | |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 166-177 | |
| P577 | publication date | 2008-07-31 | |
| P1433 | published in | Respiratory Physiology & Neurobiology | Q14256527 |
| P1476 | title | Partitioned exhaled nitric oxide to non-invasively assess asthma | |
| P478 | volume | 163 |
| Q35305384 | Biomarker-based asthma phenotypes of corticosteroid response |
| Q33875389 | Clinical patterns in asthma based on proximal and distal airway nitric oxide categories |
| Q33961279 | Clinical study of multiple breath biomarkers of asthma and COPD (NO, CO(2), CO and N(2)O) by infrared laser spectroscopy |
| Q85032415 | Corticosteroids affect nitric oxide generation, total free radicals production, and nitric oxide synthase activity in monocytes of asthmatic patients |
| Q35108583 | Elevated exhaled nitric oxide in allergen-provoked asthma is associated with airway epithelial iNOS. |
| Q53187664 | Microgravity decreases and hypergravity increases exhaled nitric oxide. |
| Q37106968 | Multiple-flow exhaled nitric oxide, allergy, and asthma in a population of older children |
| Q37078358 | Nitric oxide gas phase release in human small airway epithelial cells |
| Q89977180 | Rheotaxially Grown and Vacuum Oxidized SnOx Nanolayers for NO2 Sensing Characteristics at Ppb Level and Room Temperature |
| Q58466349 | n-3 Fatty acids and asthma |
Search more.